FDA OKs Abbott’s recharge-free Spinal Cord Stimulation device

The FDA approves Abbott’s (NYSE:ABT) Proclaim XR, its spinal cord stimulation (SCS) system, for patients with chronic pain. The company says the low-energy device features a long battery life that eliminates the need for recharging for up to 10 years.

https://seekingalpha.com/news/3501999-fda-oks-abbotts-recharge-free-scs-device